Session: Treatment
5162.0: Wednesday, November 19, 2003: 2:30 PM-4:00 PM
Oral
Treatment
Learning Objectives: Refer to the individual abstracts for learning objectives
See individual abstracts for presenting author's disclosure statement and author's information.
Moderator(s):Aimee Wilkin, MD, MPH
2:30 PMAntiretroviral Therapy (ART) utilization and opportunistic illness (OI) prophylaxis rates in a multi-site sample of HIV patients
Kelly Gebo, MD, MPH, Haya R. Rubin, MD, PhD, for the HIV Research Network
2:45 PMAppraisal and management of fatigue among HIV+ older adults *
Courtney J. Bradley, MPH, Karolynn Siegel, PhD, Helen-Maria Lekas, PhD
3:00 PMChallenges of HIV/HCV coinfection among older adults *
Karolynn Siegel, PhD, Helen-Maria Lekas, PhD, Courtney J. Bradley, MPH
3:15 PMMedication administration to children with HIV: The role and process of HIV status disclosure
Mary K. Irvine, MPH, Nancy L. VanDevanter, DrPH, Mary Arnold, NP, Renee Cohall, ACSW, Cheryl Merzel, DrPH, Danielle Greene, MPH
3:30 PMFactors influencing variations in the use of haart among hiv patients in the treatment in the united states
Justice Mbizo, MS, DrPH (c), Emmanuel A. Taylor, MSc, DrPH, Mian B. Hossain, MSC, MHS, PhD
Organized by:HIV/AIDS
Endorsed by:Socialist Caucus
CE Credits:CME, Health Education (CHES), Nursing, Pharmacy

The 131st Annual Meeting (November 15-19, 2003) of APHA